Group B streptococcus interactions with human meningeal cells and astrocytes in vitro

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Alkuwaity, Khalil ^a,c   Taylor, Alexander ^a   Heckels, John E ^a   Doran, Kelly S ^b   Christodoulides, Myron ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b SAN DIEGO STATE UNIVERSITY   (United States)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

BETA HEMOLYSIN; CYTOLYSIN; DIPALMITOYLPHOSPHATIDYLCHOLINE; HEMOLYSIN; INTERLEUKIN 8; LACTATE DEHYDROGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CANCER CELL; CELL DEATH; CELL SPECIFICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DISEASE SEVERITY; ENZYME RELEASE; FETUS; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; MENINX; NEUROLOGIC DISEASE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; STREPTOCOCCUS AGALACTIAE; SURVIVAL RATE; TOXIN SYNTHESIS;

ASTROCYTES; BACTERIAL ADHESION; BACTERIAL TOXINS; CELL DEATH; CELL LINE, TUMOR; HEMOLYSIN PROTEINS; HUMANS; MENINGES; STREPTOCOCCUS AGALACTIAE; TUMOR CELLS, CULTURED;

EID: 84865019498     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042660     Document Type: Article

References (74)

1. Heath PGT, Balfour G, Weisner AM, Efstratiou A, Lamagni TL, et al. (2004) Group B streptococcal disease in UK and Irish infants younger than 90 days. Lancet 363: 292-294.
2. Thigpen MC, Whitney CG, Messonnier NE, Zell ER, Lynfield R, et al. (2011) Bacterial meningitis in the United States, 1998-2007. New Eng J Med 364: 2016-2025.
3. Shet A, Ferrieri P, (2004) Neonatal & maternal group B streptococcal infections: A comprehensive review. Ind J Med Res 120: 141-150.
4. Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, et al. (2008) Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA 299: 2056-2065.
5. Schuchat A, (1998) Epidemiology of group B streptococcal disease in the United States: Shifting paradigms. Clin Microbiol Rev 11: 497-513.
6. Stevens JP, Eames M, Kent A, Halket S, Holt D, et al. (2003) Long term outcome of neonatal meningitis. Arch Dis Child 88: 179-184.
7. Maisey HC, Doran KS, Nizet V, (2008) Recent advances in understanding the molecular basis of group B Streptococcus virulence. Exp Rev Mol Med 10: 1-16.
8. Tazi A, Bellais S, Tardieux I, Dramsi S, Trieu-Cuot P, et al. (2012) Group B Streptococcus surface proteins as major determinants for meningeal tropism. Curr Opin Microbiol 15: 44-49.
9. Alcolado R, Weller RO, Parrish EP, Garrod D, (1988) The cranial arachnoid and pia mater in man: anatomical and ultrastructural observations. Neuropath App Neurobiol 14: 1-17.
10. Weller RO (1995) Fluid compartments and fluid balance in the central nervous system. In: Williams PL, editor. Gray's Anatomy. Edinburgh: Churchill Livingstone. pp. 1202-1204.
11. Weller RO (1995) Nervous System. In: Berry MM, Standring SM, Bannister LH, editors. Grays Anatomy. London: Churchill Livivngstone. pp. 901-1398.
12. Engelhardt B, Coisne C, (2011) Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle. Fluids Barriers CNS 8: 4.
13. Nizet V, Kim KS, Stins M, Jonas M, Chi EY, et al. (1997) Invasion of brain microvascular endothelial cells by group B streptococci. Infect Immun 65: 5074-5081.
14. Doran KS, Liu GY, Nizet V, (2003) Group B streptococcal beta-hemolysin/cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis. J Clin Invest 112: 736-744.
15. Doran KS, Engelson EJ, Khosravi A, Maisey HC, Fedtke I, et al. (2005) Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J Clin Invest 115: 2499-2507.
16. Shin S, Paul-Satyaseela M, Lee JS, Romer LH, Kim KS, (2006) Focal adhesion is involved in type III group B streptococcal invasion of human brain microvascular endothelial cells. Micro Path 41: 168-173.
17. Shin S, Kim KS, (2006) RhoA and Rac1 contribute to type III group B streptococcal invasion of human brain microvascular endothelial cells. Bichem Biophys Res Commun 345: 538-542.
18. Lembo A, Gurney MA, Burnside K, Banerjee A, de los Reyes M, et al. (2010) Regulation of CovR expression in Group B Streptococcus impacts blood-brain barrier penetration. Mol Micro 77: 431-443.
19. Tazi A, Disson O, Bellais S, Bouaboud A, Dmytruk N, et al. (2010) The surface protein HvgA mediates group B streptococcus hypervirulence and meningeal tropism in neonates. J Exp Med 207: 2313-2322.
20. Chang YC, Wang Z, Flax LA, Xu D, Esko JD, et al. (2011) Glycosaminoglycan binding facilitates entry of a bacterial pathogen into central nervous systems. Plos Path 7: Article no e1002082.
21. Maruvada R, Zhu L, Pearce D, Sapirstein A, Kim KS, (2011) Host cytosolic phospholipase A(2)alpha contributes to Group B Streptococcus penetration of the blood brain barrier. Infect Immun 79: 4088-4093.
22. Koedel U, Pfister HW, (1999) Models of experimental bacterial meningitis- Role and limitations. Infect Dis Clin Nth Amer 13: 549-577.
23. Oda Y, Nakanishi I, (1984) Ultrastructure of the mouse leptomeninx. J Comp Neurol 225: 448-457.
24. Kida S, Pantazis A, Weller RO, (1993) CSF drains directly from the subarachnoid space into nasal lymphatics in the rat. Anatomy, histology and immunological significance. Neuropath App Neurobiol 19: 480-488.
25. Mclone DG, (1980) Subarachnoid space- review. Childs Brain 6: 113-130.
26. Feurer DJ, Weller RO, (1991) Barrier functions of the leptomeninges: a study of normal meninges and meningiomas in tissue culture. Neuropath App Neurobiol 17: 391-405.
27. Kleihues P, Cavenee WK (1997) Pathology and genetics of tumours of the nervous system. Lyon, IARC.
28. Hardy SJ, Christodoulides M, Weller RO, Heckels JE, (2000) Interactions of Neisseria meningitidis with cells of the human meninges. Mol Microbiol 36: 817-829.
29. Hutchings M, Weller RO, (1986) Anatomical relationships of the pia mater to cerebral blood vessels in man. J Neurosurg 65: 316-325.
30. Wells DB, Tighe PJ, Wooldridge KG, Robinson K, Aldeen DAAA, (2001) Differential gene expression during meningeal-meningococcal interaction: Evidence for self-defense and early release of cytokines and chemokines. Infect Immun 69: 2718-2722.
31. Fowler MI, Weller RO, Heckels JE, Christodoulides M, (2004) Different meningitis-causing bacteria induce distinct inflammatory responses on interaction with cells of the human meninges. Cell Micro 6: 555-567.
32. Nizet V, Gibson RL, Chi EY, Framson PE, Hulse M, et al. (1996) Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells. Infect Immun 64: 3818-3826.
33. Major EO, Miller AE, Mourrain P, Traub RG, Dewidt E, et al. (1985) Establishment of a line of human fetal glial cells that supports Jc virus multiplication. PNAS USA 82: 1257-1261.
34. Gibson RL, Lee MK, Soderland C, Chi EY, Rubens CE, (1993) Group B Streptococci invade endothelial cells- type-III capsular polysaccharide attenuates invasion. Infect Immun 61: 478-485.
35. Tamura GS, Kuypers JM, Smith S, Raff H, Rubens CE, (1994) Adherence of Group B Streptococci to cultured epithelial cells: roles of environmental factors and bacterial surface components. Infect Immun 62: 2450-2458.
36. Charland N, Nizet V, Rubens CE, Kim KS, Lacouture S, et al. (2000) Streptococcus suis serotype 2 interactions with human brain microvascular endothelial cells. Infect Immun 68: 637-643.
37. Doran KS, Chang JCW, Benoit VM, Eckmann L, Nizet V, (2002) Group B streptococcal beta-hemolysin/cytolysin promotes invasion of human lung epithelial cells and the release of interleukin-8. J Infect Dis 185: 196-203.
38. Maisey HC, Hensler M, Nizet V, Doran KS, (2007) Group B streptococcal pilus proteins contribute to adherence to and invasion of brain microvascular endothelial cells. J Bact 189: 1464-1467.
39. Banerjee A, Kim BJ, Carmona EM, Cutting AS, Gurney MA, et al. (2011) Bacterial pili exploit integrin machinery to promote immune activation and efficient blood-brain barrier penetration. Nat Commun 2: Article 462.
40. Teti G, Tomasello F, Chiofalo MS, Orefici G, Mastroeni P, (1987) Adherence of Group B Streptococci to adult and neonatal epithelial cells mediated by lipoteichoic acid. Infect Immun 55: 3057-3064.
41. Cheng Q, Stafslien D, Purushothaman SS, Cleary P, (2002) The group B streptococcal C5a peptidase is both a specific protease and an invasin. Infect Immun 70: 3309.
42. Schubert A, Zakikhany K, Pietrocola G, Meinke A, Speziale P, et al. (2004) The fibrinogen receptor FbsA promotes adherence of Streptococcus agalactiae to human epithelial cells. Infect Immun 72: 6197-6205.
43. Winram SB, Jonas M, Chi E, Rubens CE, (1998) Characterization of group B streptococcal invasion of human chorion and amnion epithelial cells in vitro. Infect Immun 66: 4932-4941.
44. Rubens CE, Smith S, Hulse M, Chi EY, Vanbelle G, (1992) Respiratory epithelial cell invasion by Group B Streptococci. Infect Immun 60: 5157-5163.
45. Hulse ML, Smith S, Chi EY, Pham A, Rubens CE, (1993) Effect of type-III Group B Streptococcal capsular polysaccharide on invasion of respiratory epithelial cells. Infect Immun 61: 4835-4841.
46. Platt MW, (1995) In vivo hemolytic activity of Group B Streptococcus is dependent on erythrocyte-bacteria contact and independent of a carrier molecule. Current Microbiol 31: 5-9.
47. Liu GY, Doran KS, Lawrence T, Turkson N, Puliti M, et al. (2004) Sword and shield: Linked group B streptococcal beta-hemolysin/cytolysin and carotenoid pigment function to subvert host phagocyte defense. PNAS USA 101: 14491-14496.
48. Hensler ME, Miyamoto S, Nizet V, (2008) Group B Streptococcal beta-Hemolysin/Cytolysin directly impairs cardiomyocyte viability and function. Plos One 3: Article e2446.
49. Zweigner J, Jackowski S, Smith SH, van der Merwe M, Weber JR, et al. (2004) Bacterial inhibition of phosphatidylcholine synthesis triggers apoptosis in the brain. J Exp Med 200: 99-106.
50. Bryan JD, Shelver DW, (2009) Streptococcus agalactiae CspA is a serine protease that inactivates chemokines. J Bact 191: 1847-1854.
51. Levy O, (2007) Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 7: 379-390.
52. Williams PA, Bohnsack JF, Augustine NH, Drummond WK, Rubens CE, et al. (1993) Production of tumor necrosis factor by human cells in vitro and in vivo, induced by Group B Streptococci. J Pediatric 123: 292-300.
53. Wennekamp J, Henneke P, (2008) Induction and termination of inflammatory signaling in group B streptococcal sepsis. Immunol Rev 225: 114-127.
54. van Sorge NM, Quach D, Gurney MA, Sullam PM, Nizet V, et al. (2009) The Group B Streptococcal serine-rich repeat 1 glycoprotein mediates penetration of the blood brain barrier. J Infect Dis 199: 1479-1487.
55. Reiss A, Braun JS, Jaeger K, Freyer D, Laube G, et al. (2011) Bacterial pore-forming cytolysins induce neuronal damage in a rat model of neonatal meningitis. J Infect Dis 203: 393-400.
56. Truemper EJ, Smith KG, Sekar KC, (1987) Neonatal radiologic casebook. Group B streptococcal infection/cerebral necrosis. J Perinatol 7: 267-269.
57. Iijima S, Shirai M, Ohzeki T, (2007) Severe, widespread vasculopathy in late-onset group B streptococcal meningitis. Pediatric Int 49: 1000-1003.
58. Lehnardt S, Wennekamp J, Freyer D, Liedtke C, Krueger C, et al. (2007) TLR2 and caspase-8 are essential for group B streptococcus-induced apoptosis in microglial. J Immunol 179: 6134-6143.
59. Bifrare YD, Gianinazzi C, Imboden H, Leib SL, Tauber MG, (2003) Bacterial meningitis causes two distinct forms of cellular damage in the hippocampal dentate gyrus in infant rats. Hippocampus 13: 481-488.
60. McGuinness BT, Clarke IN, Lambden PR, Barlow AK, Poolman JT, et al. (1991) Point mutation in meningococcal porA gene associated with increased endemic disease. Lancet 337: 514-517.
61. Nowicki B, Vuopiovarkila J, Viljanen P, Korhonen TK, Makela PH, (1986) Fimbrial phase variation and systemic Escherichia coli infection studied in the mouse peritonitis model. Micro Path 1: 335-347.
62. Marchlewicz BA, Duncan JL, (1980) Properties of a hemolysin Produced by Group B Streptococci. Infect Immun 30: 805-813.
63. Fowler MI, Yin KYHW, Humphries HE, Heckels JE, Christodoulides M, (2006) Comparison of the inflammatory responses of human meningeal cells following challenge with Neisseria lactamica and with Neisseria meningitidis. Infect Immun 74: 6467-6478.
64. Vaudaux P, Waldvogel FA, (1979) Gentamicin antibacterial activity in the presence of human polymorphonuclear leukocytes. Antimicrob Agent Chemother 16: 743-749.
65. Elsinghorst EA, (1994) Measurement of invasion by gentamicin resistance. Bact Path, Pt B 236: 405-420.
66. Christodoulides M, Everson JS, Liu B, Lambden PR, Watt PJ, et al. (2000) Interaction of primary human endometrial cells with Neisseria gonorrhoeae expressing green fluorescent protein. Mol Microbiol 35: 32-43.
67. Christodoulides M, Makepeace BL, Partridge K, Kaur D, Fowler MI, et al. (2002) Interaction of Neisseria meningitidis with human meningeal cells induces the secretion of a distinct group of chemotactic, pro-inflammatory and growth-factor cytokines. Infect Immun 70: 4035-4044.
68. Madoff LC, Michel JL, Kasper DL, (1991) A monoclonal antibody identifies a protective C-Protein alpha-antigen epitope in Group B Streptococci. Infect Immun 59: 204-210.
69. Pritzlaff CA, Chang JCW, Kuo SP, Tamura GS, Rubens CE, et al. (2001) Genetic basis for the beta-haemolytic/cytolytic activity of group B Streptococcus. Mol Micro 39: 236-247.
70. Lancefield RC, Mccarty M, Everly WN, (1975) Multiple mouse-protective antibodies directed against Group B Streptococci- special reference to antibodies effective against protein antigens. J Exp Med 142: 165-179.
71. Glaser P, Rusniok C, Buchrieser C, Chevalier F, Frangeul L, et al. (2002) Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol Microbiol 45: 1499-1513.
72. Martin TR, Rubens CE, Wilson CB, (1988) Lung antibacterial defense mechanisms in infant and adult rats- implications for the pathogenesis of Group B Streptococcal infections in the neonatal lung. J Infect Dis 157: 91-100.
73. Yim HH, Nittayarin A, Rubens CE, (1997) Analysis of the capsule synthesis locus, a virulence factor in group B streptococci. Streptococci and the Host 418: 995-997.
74. Wilkinson HW, (1977) Nontypable Group B Streptococci isolated from human sources. J Clin Micro 6: 183-184.